Skip to main content

Peer Review reports

From: Large variation in anti-factor Xa levels with nadroparin as thromboprophylaxis in COVID-19 and non-COVID-19 critically ill patients

Original Submission
20 Jun 2023 Submitted Original manuscript
11 Dec 2023 Reviewed Reviewer Report - Pavel Suk
12 Dec 2023 Reviewed Reviewer Report
4 Jan 2024 Author responded Author comments - Monique M.R. de Maat
Resubmission - Version 2
4 Jan 2024 Submitted Manuscript version 2
5 Jan 2024 Author responded Author comments - Monique M.R. de Maat
Resubmission - Version 3
5 Jan 2024 Submitted Manuscript version 3
Publishing
12 Jan 2024 Editorially accepted
6 Feb 2024 Article published 10.1186/s40360-024-00733-x

You can find further information about peer review here.

Back to article page